UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 14.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,659,367 shares of the company’s stock after acquiring an additional 208,813 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.82% of DocuSign worth $103,030,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Massmutual Trust Co. FSB ADV boosted its stake in DocuSign by 5,000.0% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $27,000 after acquiring an additional 500 shares during the last quarter. Mather Group LLC. boosted its stake in DocuSign by 4,338.5% during the 2nd quarter. Mather Group LLC. now owns 577 shares of the company’s stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Brooklyn Investment Group bought a new position in DocuSign during the 3rd quarter valued at $33,000. Reston Wealth Management LLC bought a new position in DocuSign during the 3rd quarter valued at $47,000. Finally, nVerses Capital LLC bought a new position in DocuSign during the 2nd quarter valued at $48,000. 77.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Citigroup increased their price objective on shares of DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Wells Fargo & Company raised their price target on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a research report on Friday, September 6th. Robert W. Baird raised their price target on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Bank of America raised their price target on shares of DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, JMP Securities raised their price target on shares of DocuSign from $84.00 to $108.00 and gave the stock a “market outperform” rating in a research report on Friday, November 22nd. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $65.80.

DocuSign Stock Down 0.9 %

DOCU stock opened at $79.69 on Monday. DocuSign, Inc. has a fifty-two week low of $42.76 and a fifty-two week high of $86.75. The firm’s 50-day simple moving average is $71.99 and its 200 day simple moving average is $61.08. The stock has a market cap of $16.17 billion, a PE ratio of 16.81, a price-to-earnings-growth ratio of 8.25 and a beta of 0.90.

DocuSign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million for the quarter, compared to analysts’ expectations of $727.20 million. During the same quarter last year, the company earned $0.09 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts forecast that DocuSign, Inc. will post 1.03 EPS for the current fiscal year.

Insider Buying and Selling

In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the firm’s stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total transaction of $820,752.54. Following the transaction, the insider now owns 70,748 shares of the company’s stock, valued at approximately $3,923,684.08. This trade represents a 17.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 14,036 shares of the firm’s stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.47, for a total transaction of $778,576.92. Following the transaction, the chief financial officer now directly owns 87,611 shares in the company, valued at approximately $4,859,782.17. The trade was a 13.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 69,558 shares of company stock valued at $4,272,768 in the last quarter. Company insiders own 1.66% of the company’s stock.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.